% | $
Quotes you view appear here for quick access.

Capstone Turbine Corp. Message Board

extractofhuman 3 posts  |  Last Activity: May 5, 2016 8:16 AM Member since: May 21, 2009
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • extractofhuman by extractofhuman May 5, 2016 8:16 AM Flag

    NEW YORK-- Synergy Pharmaceuticals Inc. (NASDAQ:SGYP), a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies, today announced that it has entered into definitive agreements with certain institutional investors to sell 29,948,334 shares of common stock at a price of $3.00 per share.

    The shares were offered and sold directly to institutional investors by the company in a registered direct offering conducted without an underwriter or placement agent. The net proceeds from the offering, after deducting estimated offering expenses, will be approximately $89.7 million. The offering is expected to close on or about May 6, 2016.

    Synergy intends to use the net proceeds from the offering to fund its commercialization activities for plecanatide, further clinical development of plecanatide and dolcanatide and for working capital and other general corporate purposes.

    Sentiment: Hold

  • extractofhuman extractofhuman May 5, 2016 12:02 AM Flag

    " Soli coming to the market during this years flu season." Uhhh you do realize Solithromycin is an antibiotic, won't work against the flu -which is caused by viruses. but hey, pump it up!

    Sentiment: Hold

  • Reply to

    New report on Linzess

    by theshahlawfirm Apr 26, 2016 11:28 AM
    extractofhuman extractofhuman Apr 28, 2016 1:56 PM Flag

    Here's the update: The IRWD report was removed from PhaseFiveResearch site in response to a complaint from the FAERS(FDA Adverse Event Reporting System) data source. So there is no bad news for IRWD. Which is why it's back up today.

    Sentiment: Hold

1.41-0.05(-3.42%)11:57 AMEDT